Breaking News, Financial News

Financial Report: BASi

Revenues up 7% in the quarter driven by Culex sales

By: Kristin Brooks

Managing Editor, Contract Pharma

BASi
 
1Q Revenues: $6.2 million (+7%)
 
1Q Loss: $662,000 (earnings were $256 million 1Q12)
 
Comments: Service revenue was up 5% to $4.9 million. Product revenue increased 15% to $1.3 million, primarily due to higher sales of Culex automated sampling systems. Results include the impact of a change in warrant liability of $961,000 and a payment of $1.2 million to the company’s line of credit.
 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters